The Vector Institute today launched UnBias-Plus , a free, open-source AI tool built by Vector's AI Safety research scientists that helps detect, explain, and rewrite biased language in written content ...

Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...

A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, ...

FOXO Technologies Inc. (OTC: FOXOD/FOXO) (the “Company”) announces the following mid-year update to shareholders by the Company’s Chief Executive Officer Seamus Lagan. FOXO Shareholders: As we have ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...

Hereditary hearing loss affects millions globally, with mutations in the SLC26A4 gene among the most common genetic triggers, ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable a ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturingIntravacc offers four ...

Ten people who were born deaf heard sound for the first time after receiving a single injection of gene therapy into the inner ear. The patients, ranging in age from 1.5 to 23.9 years, all carried ...

Global cybersecurity spending is forecast to exceed $300 billion in 2026, and the catalyst is no longer abstract. AI agents now outnumber human identities within enterprises by roughly 109 to 1; ...